Moderna, Inc. (MRNA)
138.82
-6.31
(-4.35%)
USD |
NASDAQ |
Aug 24, 16:00
139.00
+0.18
(+0.13%)
After-Hours: 19:58
Moderna 1 Year Total Returns (Daily) : 453.5% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 453.5% |
| August 20, 2026 | 395.8% |
| August 19, 2026 | 524.8% |
| August 18, 2026 | 124.1% |
| August 17, 2026 | 130.0% |
| August 14, 2026 | 137.2% |
| August 13, 2026 | 136.7% |
| August 12, 2026 | 148.1% |
| August 11, 2026 | 137.8% |
| August 10, 2026 | 129.0% |
| August 07, 2026 | 122.4% |
| August 06, 2026 | 101.6% |
| August 05, 2026 | 104.8% |
| August 04, 2026 | 106.2% |
| August 03, 2026 | 99.75% |
| July 31, 2026 | 85.45% |
| July 30, 2026 | 80.16% |
| July 29, 2026 | 66.84% |
| July 28, 2026 | 64.57% |
| July 27, 2026 | 62.90% |
| July 24, 2026 | 58.98% |
| July 23, 2026 | 64.46% |
| July 22, 2026 | 77.42% |
| July 21, 2026 | 92.64% |
| July 20, 2026 | 90.31% |
| Date | Value |
|---|---|
| July 17, 2026 | 91.99% |
| July 16, 2026 | 96.97% |
| July 15, 2026 | 116.2% |
| July 14, 2026 | 105.2% |
| July 13, 2026 | 99.20% |
| July 10, 2026 | 99.15% |
| July 09, 2026 | 133.5% |
| July 08, 2026 | 126.8% |
| July 07, 2026 | 166.8% |
| July 06, 2026 | 168.3% |
| July 02, 2026 | 163.4% |
| July 01, 2026 | 152.7% |
| June 30, 2026 | 153.8% |
| June 29, 2026 | 156.6% |
| June 26, 2026 | 144.3% |
| June 25, 2026 | 122.4% |
| June 24, 2026 | 125.4% |
| June 23, 2026 | 137.6% |
| June 22, 2026 | 129.1% |
| June 18, 2026 | 151.8% |
| June 17, 2026 | 141.9% |
| June 16, 2026 | 113.1% |
| June 15, 2026 | 95.46% |
| June 12, 2026 | 82.49% |
| June 11, 2026 | 78.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| BioNTech SE | 5.24% |
| Kailera Therapeutics, Inc. | -- |
| Sarepta Therapeutics, Inc. | -6.33% |
| Replimune Group, Inc. | 163.8% |
| Intellia Therapeutics, Inc. | 26.81% |